To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
49 Current news of Stanford University
rss
2012 Nobel Prize in Chemistry Uses Research Equipment Engineered Locally from BMG LABTECH
16-10-2012
Robert J. Lefkowitz from Duke University, along with Brian Kobilka from Stanford University, were just awarded the 2012 Nobel Prize in Chemistry for their research and discovery of the receptor protein that binds to adrenaline, that is the beta-adrenergic receptor. A receptor protein crosses ...
Blocking key protein could halt age-related decline in immune system, Stanford study finds
02-10-2012
The older we get, the weaker our immune systems tend to become, leaving us vulnerable to infectious diseases and cancer and eroding our ability to benefit from vaccination. Now Stanford University School of Medicine scientists have found that blocking the action of a single protein whose ...
Stanford researchers first to determine entire genetic sequence of individual human sperm
24-07-2012
The entire genomes of 91 human sperm from one man have been sequenced by Stanford University researchers. The results provide a fascinating glimpse into naturally occurring genetic variation in one individual, and are the first to report the whole-genome sequence of a human gamete — the only ...
RNA regulator of melanoma could be a new target for cancer therapy
10-05-2012
Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published in Genome Research, researchers have identified a previously unknown ...
Not all tumor cells are equal
Stanford study reveals huge genetic diversity in cells shed by tumors
09-05-2012
The cells that slough off from a cancerous tumor into the bloodstream are a genetically diverse bunch, Stanford University School of Medicine researchers have found. Some have genes turned on that give them the potential to lodge themselves in new places, helping a cancer spread between ...
Stanford-spawned nanoparticles home in on brain tumors, boost accuracy of surgical removal
18-04-2012
Like special-forces troops laser-tagging targets for a bomber pilot, tiny particles that can be imaged three different ways at once have enabled Stanford University School of Medicine scientists to remove brain tumors from mice with unprecedented accuracy.In a study to be published in Nature ...
Stanford researchers boost potency, reduce side effects of IL-2 protein used to treat cancer
20-03-2012
The utility of a naturally occurring protein given, sometimes to great effect, as a drug to treat advanced cancers is limited by the severe side effects it sometimes causes. But a Stanford University School of Medicine scientist has generated a mutant version of the protein whose modified ...
New biosensor microchip could speed up drug development, Stanford researchers say
26-04-2011
Stanford researchers have developed a new biosensor microchip that could significantly speed up the process of drug development. The microchips, packed with highly sensitive "nanosensors," analyze how proteins bind to one another, a critical step for evaluating the effectiveness and possible ...
How disordered proteins spread from cell to cell, potentially spreading disease
21-02-2011
One bad apple is all it takes to spoil the barrel. And one misfolded protein may be all that's necessary to corrupt other proteins, forming large aggregations linked to several incurable neurodegenerative diseases such as Huntington's, Parkinson's and Alzheimer's.Stanford biology Professor ...
RevaTen platelet-rich plasma shows promise as potential treatment for heart attacks
19-01-2011
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart attack). The findings were published in Cardiovascular ...
Netmeeting
